On Thursday, Perrigo Company plc Ordinary Shares (NYSE:PRGO)’s shares declined -2.07% to $199.00.
Yesterday, Perrigo Company plc Ordinary Shares (PRGO), declared that it has received final Federal Drug Administration approval for Triamcinolone Acetonide Topical Aerosol, the generic version of Sun Pharma’s Kenalog® nasal spray. Our first to market shipments to our pharmacy customers have commenced.
Kenalog® Spray (Triamcinolone Acetonide Topical Aerosol, USP) is indicated for relief of the inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Annual sales were about $16 million according to IMS Health.
Perrigo’s Chairman, President and CEO Joseph C. Papa stated, “This launch is another example of Perrigo’s investment and commitment to making quality healthcare more affordable for all consumers across the globe.”
Perrigo Company plc, through its auxiliaries, develops, manufactures, and distributes over-the-counter (OTC) and generic prescription (Rx) pharmaceuticals, nutritional products, and active pharmaceutical ingredients (API). Its Consumer Healthcare segment offers OTC pharmaceutical products in the areas of analgesics, cough/cold/allergy/sinus, gastrointestinal, smoking cessation, and animal health products, in addition to in the areas of feminine hygiene, diabetes care, and dermatological care; and contract manufacturing services.
Amarin Corporation plc (ADR) (NASDAQ:AMRN)’s shares dropped -2.07% to $2.37, during the last trading session on Thursday.
On April 8, Amarin Corporation (AMRN), and Walk with a Doc, a national nonprofit organization, declared a 2015 partnership to expand the reach of their national health awareness efforts.
Walk with a Doc is a free participation, year-round walking program held in communities across the United States and abroad. The program is dedicated to encouraging healthy physical activity in people of all ages with the aim of reversing the consequences of a sedentary lifestyle and improving health and well-being. Each walk is hosted by local physicians in public spaces and everyone is welcome.
Dr. David Sabgir, cardiologist and founder of Walk with a Doc, stated, “Amarin’s work to educate patients about very high triglycerides positions them as a great partner for our programs. Through this collaboration, we are working together to raise awareness of the importance of lipid administration, diet and exercise to assist improve the overall health of our local communities.”
“This partnership with Walk with a Doc meaningfully complements the Lower My Trigs™ campaign,” said John Thero, President and Chief Executive Officer of Amarin. “We saw the initiative Walk with a Doc was taking in local communities across the country and we wanted to support that effort and get involved. Regardless of medical condition, proper diet and exercise is always paramount in achieving quality outcomes. We’re happy to be a part of this exciting program that has the potential to positively influence so many people.”
Amarin Corporation plc, a biopharmaceutical company, focuses on developing and commercializing therapeutics for the treatment of cardiovascular diseases in the United States. The company’s lead product comprises Vascepa, a prescription-only omega-3 fatty acid capsule, used as an adjunct to diet for reducing triglyceride levels in adult patients with severe hypertriglyceridemia.
At the end of Thursday’s trade, Wynn Resorts, Limited (NASDAQ:WYNN)‘s shares dipped -2.05% to $127.35.
Yesterday, Steve Wynn, Chairman and CEO of Wynn Resorts (WYNN), issued the following statement in response to Elaine Wynn’s press release dated April 16, 2015:
“My comments on The Charlie Rose Show should not be misconstrued. Decisions about nominations and re-nominations of directors are the responsibility of independent directors of Wynn Resorts Limited. They have made the decision about the re-nomination of Elaine Wynn for the reasons which they have thoroughly and carefully explained to our stockholders. The Company’s independent directors are focused on the best interests of our stockholders and fulfill their roles extremely well for our Company. Under the stockholders contract (which Ms. Wynn seeks to invalidate through litigation), I am obligated to vote in favor of Ms. Wynn’s re-election.
“It is very important that all stockholders know that I have nothing but the highest respect for the independent directors, their business judgment and their overriding sense of fiduciary responsibility to Wynn Resorts and its stockholders.”
Wynn Resorts, Limited, together with its auxiliaries, develops, owns, and operates destination casino resorts. It operates in two segments, Macau Operations and Las Vegas Operations. The company operates Wynn Macau and Encore at Wynn Macau resort located in the People’s Republic of China.
Oasis Petroleum Inc (NYSE:OAS), ended its Thursday’s trading session with -2.03% loss, and closed at $18.34.
On April 14, Oasis Petroleum Inc. declared that the lenders under its revolving credit contract accomplished their regular semi-annual redetermination of the borrowing base, resulting in a borrowing base of $1,700 million. The Company raised the lenders’ aggregate elected commitment to $1,525 million from $1,500 million. The lenders’ aggregate commitment can be raised to the full $1,700 million borrowing base by increasing the commitment of one or more lenders.
Additionally, the Company extended the maturity date of the facility from April 2018 to April 2020, offered that the Company’s 2019 Senior Notes are stepped down or refinanced 90 days proceeding to the maturity of the 2019 Senior Notes. Oasis’ borrowing base facility is supported by 18 financial institutions. The next redetermination of the borrowing base is planned for October 1, 2015.
First Quarter 2015 Plan
Oasis plans to declare its first quarter 2015 financial and operational results on Wednesday, May 6, 2015 after the close of trading on the NYSE. Additionally, the Company will host a conference call on Thursday, May 7, 2015 at 10:00 a.m. Central Time to talk about financial and operational results for the quarter.
Oasis Petroleum Inc., an independent exploration and production company, focuses on the acquisition and development of unconventional oil and natural gas resources in the North Dakota and Montana regions of the Williston Basin. The company’s principal projects are located in West Williston and East Nesson. As of December 31, 2014, it had 505,503 net leasehold acres in the Williston Basin; and about 272.1 million barrels of oil equivalent of estimated net proved reserves.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
